Gleam Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 2.00 M
- Company Age 24 Year, 9 Days
- Last Filing with ROC 31 Mar 2010
- Open Charges ₹ 1.71 Cr
- Satisfied Charges ₹ 5.66 M
About Gleam Pharmaceuticals
Gleam Pharmaceuticals Private Limited (GPPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 February 2001 and has a history of 24 years. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2010. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹1.71 Cr. The company has closed loans amounting to ₹5.66 M, as per Ministry of Corporate Affairs (MCA) records.
Priya Palbag and Gopa Bhattacharyya serve as directors at the Company.
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U27101WB2001PTC092902
- Company No.
092902
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Feb 2001
- Date of AGM
30 Sep 2010
- Date of Balance Sheet
31 Mar 2010
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Gleam Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Priya Palbag  | Director | 15-Feb-2001 | Current |
| Gopa Bhattacharyya | Director | 15-Feb-2001 | Current |
Financial Performance of Gleam Pharmaceuticals.
Enhance accessibility to Gleam Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Gleam Pharmaceuticals?
Unlock access to Gleam Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
G N K Drugs Co Pvt LtdPriya Palbag is a mutual person
Charges (Loans)
₹17.11 M
₹5.66 M
Charges Breakdown by Lending Institutions
- Idbi Bank Limited : 1.70 Cr
- State Bank Of India : 0.01 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Aug 2009 | Idbi Bank Limited | ₹1.70 Cr | Open |
| 13 Apr 2005 | State Bank Of India | ₹0.11 M | Open |
| 02 May 2007 | State Bank Of Mysore | ₹2.80 M | Satisfied |
| 10 Jun 2005 | Bank Of India | ₹1.83 M | Satisfied |
| 10 Jun 2005 | Bank Of India | ₹1.03 M | Satisfied |
How Many Employees Work at Gleam Pharmaceuticals?
Unlock and access historical data on people associated with Gleam Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gleam Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gleam Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.